Role of Interim 18F-FLT PET/CT for Outcome Prediction in Pancreatic Adenocarcinoma

NCT03318497 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Adenocarcinoma

Interventions

DRUG: 3'-deoxy-3'-[F-18] fluorothymidine: [F-18]FLT
PROCEDURE: Computed Tomography
PROCEDURE: Positron Emission Tomography
OTHER: Laboratory Biomarker Analysis

Sponsor

University of Texas Southwestern Medical Center